DN
Darlene Noci (Chief Development Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $2.8M of NUVL (23,000 sh × $123.59, as filed), executed Jul 1. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.9M
shares × price, as filed
Last traded
Jul 1
Filed Jul 6
Median ADV $288.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $14.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
11 filings
Sector per market data · by filing · past 12 months
Most traded names
NUVLRecent filings
NUVLSALE
Nuvalent Inc
View filing →
$298K4,000 sh × $74.56
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $226K
3,100 sh × $72.91
Exec Mar 27 2025
Filed Mar 28 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $2.4M
32,900 sh across 4 lots
Exec Mar 6 2025
Filed Mar 10 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $175K
2,173 sh × $80.54
Exec Jan 6 2025
Filed Jan 8 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $398K
4,500 sh across 2 lots
Exec Nov 1 2024
Filed Nov 4 2024 · 5:30 PM ET